Article
BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence.
Surgery - 1 Dec 2012
Prescott Jason D, Sadow Peter M, Hodin Richard A, Le Long Phi, Gaz Randall D, Randolph Gregory W, Stephen Antonia E, Parangi Sareh, Daniels Gilbert H, Lubitz Carrie C
Abstract excerpt
BACKGROUND: Papillary thyroid cancer (PTC) recurrence risk is difficult to predict. No current risk classification system incorporates BRAF mutational status. Here, we assess the incremental value of BRAF mutational status in predicting PTC recurrence relative to existing recurrence risk algorithms. METHODS: Serial data were collected for a historical cohort having undergone total thyroidectomy for papillary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.